Education Information: Cardiff achieves ‘Champion’ status for gender equality in physics | Parent Interventions: Online survey to assess needs of children and young people with cancer | Parent Interventions: Study links severe childhood deprivation to difficulties in adulthood | Parent Interventions: New study aims to learn the lessons of homeschooling | Teacher Insights: Using e-learning to raise biosecurity awareness | National Edu News: Science and Technology in finding solutions to combat COVID-19 | National Edu News: Ek Bharat Shreshtha Bharat programme | Health Monitor: Beware of Hepatitis D, It can Lead to Hepatocellular Carcinoma | Teacher Insights: Education project to understand Birmingham learning at home during COVID-19 | Education Information: UoG launches new onlines to meet some of the challenges of Covid-19 | Teacher Insights: Professor Woolfson awarded Humboldt Research Prize | Parent Interventions: Parents paying heavy price for lockdown | Teacher Insights: Great Science Share brings science investigations into homes | Education Information: App will reduce high risk of falls during and after Lockdown | Education Information: University of Manchester to decarbonise its investment portfolio |

May 07, 2020 Thursday 10:50:21 PM IST

Scientists to culture novel coronavirus in human lung epithelial cell

Centre for Cellular and Molecular Biology (CCMB), Hyderabad has tied up with a Bengaluru-based company, Eyestem Research Private Limited, to take up research activities on COVID-19. Through this research collaboration, an attempt will be made to grow novel coronavirus in human cell lines, which will enable in vitro testing of potential drugs and vaccines against the COVID-19. The research team will use Eyestem's human lung epithelial cell culture system provided as part of its Anti-COVID Screening (ACS) platform to understand the molecular and pathological characteristics of the novel coronavirus, with a view of establishing a rational basis for testing potential drugs in vitro, said CCMB scientists.

CCMB is a constituent laboratory of the Council of Scientific and Industrial Research (CSIR) known for its cutting-edge research work on cellular and molecular biology. Eyestem Research Private Limited is a cell therapy start-up incubated at the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru. C-CAMP is an initiative of the Department of Biotechnology, Ministry of Science and Technology.

Dr. Jogin Desai, CEO, Eyestem, expressed hope that CCMB will be able to leverage its platform and advance COVID-19 research that will help the country. “The ACS platform has been developed by Dr. Rajarshi Pal and his team and is a testament to our depth and expertise in cell therapy and disease modeling,” he said.

Eyestemis working to democratize access to cell therapy as well as disease modeling platforms and bring their benefit to a large section of humanity, added Dr. Desai.